Skip to content

Astrazeneca announces forxiga® will be listed on the pbs for Australians living with symptomatic heart failure with reduced ejection fraction

By Gold Cross - December 21, 2021

This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Article tags

Articles you might be interested in

, ,

The Pharmacy Guild of Australia, Queensland thanks outgoing Premier the Hon Annastacia Palaszczuk

Gold Cross | December 11, 2023
,

Capital Chemist Pharmacy of the Year

Gold Cross | December 11, 2023
, ,

Pharmacy Guild Queensland appoints Matthew Battams as Branch Director

Gold Cross | December 8, 2023
, , ,

BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University

Gold Cross | December 8, 2023
BD Rowa automation gives you back 6 hours in your day

Latest Posts

BrainTrack receives international recognition
Gold Cross | December 11, 2023
Capital Chemist Pharmacy of the Year
Gold Cross | December 11, 2023
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Gold Cross | December 8, 2023

Featured Posts

The Pharmacy Guild of Australia, Queensland thanks outgoing Premier the Hon Annastacia Palaszczuk
Gold Cross | December 11, 2023
Pharmacy Guild Queensland appoints Matthew Battams as Branch Director
Gold Cross | December 8, 2023
What did COVID cost Australia’s health service?
Gold Cross | December 5, 2023

Tags

Scroll To Top